Drugs / ovarian cancer peptide vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00091273 | Jun 2004 → Feb 2006 | ovarian cancer, primary peritoneal carcinoma | University of Virginia | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ovarian cancer peptide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00091273 ↗ |
| Modality | Vaccine | “Peptide Vaccine” NCT00091273 ↗ |
| Route | Other | “subcutaneously and intradermally” NCT00091273 ↗ |
| Route | Subcutaneous | “subcutaneously and intradermally” NCT00091273 ↗ |